Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Cost of Revenue: 2020-2024

Historic Cost of Revenue for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $20.9 million.

  • Journey Medical's Cost of Revenue rose 28.72% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year increase of 9.30%. This contributed to the annual value of $20.9 million for FY2024, which is 8.80% down from last year.
  • Journey Medical's Cost of Revenue amounted to $20.9 million in FY2024, which was down 8.80% from $22.9 million recorded in FY2023.
  • Journey Medical's Cost of Revenue's 5-year high stood at $32.1 million during FY2021, with a 5-year trough of $14.6 million in FY2020.
  • For the 3-year period, Journey Medical's Cost of Revenue averaged around $24.8 million, with its median value being $22.9 million (2023).
  • In the last 5 years, Journey Medical's Cost of Revenue surged by 119.84% in 2021 and then decreased by 25.61% in 2023.
  • Yearly analysis of 5 years shows Journey Medical's Cost of Revenue stood at $14.6 million in 2020, then soared by 119.84% to $32.1 million in 2021, then dropped by 4.08% to $30.8 million in 2022, then dropped by 25.61% to $22.9 million in 2023, then dropped by 8.80% to $20.9 million in 2024.